NCT07034612

Brief Summary

This prospective observational study investigates the impact of pulsatile versus non-pulsatile cardiopulmonary bypass (CPB) flow on choroidal circulation in diabetic and non-diabetic patients undergoing elective coronary artery bypass grafting (CABG). A total of 104 patients aged 30 to 70 years will be included, with balanced distribution between diabetic and non-diabetic groups. Optical coherence tomography angiography (OCTA) will be performed preoperatively and at 1 month postoperatively to assess changes in choroidal vascularity. The primary objective is to determine whether the type of CPB flow affects choroidal microcirculation, particularly in diabetic patients. The findings may support more individualized perfusion strategies in patients at risk of ocular microvascular impairment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 14, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 24, 2025

Completed
Last Updated

June 27, 2025

Status Verified

June 1, 2025

Enrollment Period

2 years

First QC Date

June 14, 2025

Last Update Submit

June 24, 2025

Conditions

Keywords

Diabetic RetinopathyCardiopulmonary BypassPulsatile Flow

Outcome Measures

Primary Outcomes (1)

  • Change in Choroidal Vascularity Index (CVI) from Baseline to 1-Month Postoperative

    CVI will be calculated from OCTA images preoperatively and 1 month postoperatively. Mean change in CVI will be compared between pulsatile and non-pulsatile CPB groups.

    1 month after surgery

Secondary Outcomes (3)

  • Change in Retinal Vascular Density (RVD)

    1 month after surgery

  • Change in Foveal Avascular Zone (FAZ) Area

    1 month after surgery

  • Comparison of CVI Change Between Diabetic and Non-Diabetic Patients

    1 month after surgery

Study Arms (4)

Diabetic - Pulsatile Flow

Diabetic patients undergoing elective coronary artery bypass grafting (CABG) with pulsatile cardiopulmonary bypass (CPB) flow. Preoperative and postoperative 1st month OCTA measurements will be taken.

Diabetic - Non-Pulsatile Flow

Diabetic patients undergoing elective CABG with non-pulsatile CPB flow. OCTA measurements preoperatively and at 1 month postoperatively.

Non-Diabetic - Pulsatile Flow

Non-diabetic patients undergoing elective CABG with pulsatile CPB flow. OCTA measurements preoperatively and at 1 month postoperatively.

Non-Diabetic - Non-Pulsatile Flow

Non-diabetic patients undergoing elective CABG with non-pulsatile CPB flow. OCTA measurements preoperatively and at 1 month postoperatively.

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for elective coronary artery bypass grafting, including diabetic and non-diabetic individuals, recruited at a single center (Samsun Training and Research Hospital).

You may qualify if:

  • Age between 30 and 70 years
  • Undergoing elective, first-time coronary artery bypass graft surgery (CABG)
  • Stable metabolic status
  • For diabetic group: history of diabetes mellitus for more than 10 years
  • No significant ocular media opacity (e.g., cataract or vitreous hemorrhage)
  • No tremor or condition interfering with OCTA imaging
  • Aortic cross-clamp time ≤ 120 minutes

You may not qualify if:

  • Age \<30 or \>70 years
  • Re-do or emergency cardiac surgery
  • Diabetes duration \<10 years (for diabetic group)
  • Unstable metabolic state or active infection
  • Presence of significant cataract, vitreous hemorrhage, or tremor
  • Contraindications to OCTA imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsun University Faculty of Medicine

Samsun, 55090, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetic Retinopathy

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2025

First Posted

June 24, 2025

Study Start

January 1, 2023

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

June 27, 2025

Record last verified: 2025-06

Locations